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Abstract
Background: Inadequate cervical smears cannot be analysed, can cause distress to women, are a
financial burden to the NHS and may lead to further unnecessary procedures being undertaken.
Furthermore, the proportion of inadequate smears is known to vary widely amongst providers.
This study investigates this variation using Shewhart's theory of variation and control charts, and
suggests strategies for addressing this.
Methods: Cervical cytology data, from six laboratories, serving 100 general practices in a former
UK Health Authority area were obtained for the years 2000 and 2001. Control charts of the
proportion of inadequate smears were plotted for all general practices, for the six laboratories and
for the practices stratified by laboratory. The relationship between proportion of inadequate
smears and the proportion of negative, borderline, mild, moderate or severe dyskaryosis as well as
the positive predictive value of a smear in each laboratory was also investigated.
Results: There was wide variation in the proportion of inadequate smears with 23% of practices
showing evidence of special cause variation and four of the six laboratories showing evidence of
special cause variation.
There was no evidence of a clinically important association between high rates of inadequate
smears and better detection of dyskaryosis (R2 = 0.082).
Conclusions: The proportion of inadequate smears is influenced by two distinct sources of
variation – general practices and cytology laboratories, which are classified by the control chart
methodology as either being consistent with common or special cause variation. This guidance
from the control chart methodology appears to be useful in delivering the aim of continual
improvement.
Background
Each year some 3.6 million women in England have a cer-
vical smear taken following an invitation from the
national screening programme[1]. The proportion of
these that do not contain material suitable for analysis
and, are therefore deemed inadequate[1], has risen from
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around 6% in the early 1990s to 9.7% in 2000–1[1].
Women who have an inadequate smear must be retested,
in line with national guidelines, and women who have
three successive inadequate smears are referred for colpos-
copy[2]. Inadequate smears are therefore a source of dis-
tress to women, and a waste of resources in general
practices, clinics and cytology laboratories[1].
There is wide variation in the proportion of inadequate
smears between providers. This paper analyses this varia-
tion using Walter Shewhart's theory of variation which
classifies variation as either emanating from a "common
cause" or a "special cause" and gives guidance on the
appropriate action required to address these two types of
variation and so deliver continual improvement.
Common cause variation is expected variation attributa-
ble to "chance". It is part of every process and affects eve-
ryone in that process. To reduce common cause variation
we need to fundamentally change the underlying process.
In contrast, special cause variation is exceptional variation
not attributable to "chance", but arising from special cir-
cumstances and therefore not affecting everyone in that
process. Special cause variation can produce exceptionally
good or bad results. To reduce unfavourable special cause
variation we need to identify the special cause and act on
it. In the case of favourable special cause variation, we
likewise need to investigate and learn the lessons therein
for the benefit of others.
Shewhart's methods have been widely used in industry
[3,4], in laboratory settings [5], and in communicable dis-
eases control [6,7]. The use of control charts has been sug-
gested in clinical governance and health care performance
monitoring [8,9]. This paper reports an investigation of
variation in the proportion of inadequate smears in South
Staffordshire Health Authority using control charts.
Methods
Cervical cytology data routinely collected by the Health
Authority from the laboratories serving the district was
obtained for all 100 general practices in South Stafford-
shire. The data included the number of smears taken and
the number inadequate for the calendar years 2000 and
2001.
We investigated two distinct sources of variation – varia-
tion by general practice and variation by cytology labora-
tory. We undertook these analyses using P-charts. P-charts
are one member of the family of control charts and are
designed to be used with binomial data (inadequate
smear – yes/no) which is expressed as a proportion of the
sample size. We sorted our data by the total number of
smears (ie sample size) and plotted our P-charts with
respect to this order. This has two advantages. Firstly the
resulting P-charts show the impact of sample size on the
control limits, and secondly the resulting control limits
are easy on the eye because they appear like a funnel. Such
plots have been advocated in health care [10].
National comparative data, which included the propor-
tion of inadequate smears, the proportion of smears clas-
sified as mild dyskariosis, severe dyskariosis and the
positive predictive value of a smear, was obtained for all
156 laboratories in England for the years 2000–2001[1].
The relationship between the proportion of smears classi-
fied as inadequate by a laboratory and the positive predic-
tive value of a smear in that laboratory was investigated by
linear regression analysis. The relationship between the
proportion of smears classified as inadequate and the pro-
portion of smears classified as negative (no dyskariosis),
mild dyskariosis, moderate dyskariosis or severe dyskario-
sis was investigated by step-down multivariate regression.
All analysis was carried out using SPSS 11.0. For the step-
down analysis the proportion of inadequate smears was
the dependent variable and the proportion categorised as
negative, borderline, mild, moderate and severe dyskario-
sis were independent variables. The regression was
repeated with non-significant variables eliminated in a
stepwise fashion.
Results
Analysis of inadequate smears by general practice
Inter-general practice variation in the proportion of inad-
equate smears was explored using a P-chart for our 100
general practices (Figure 1). There is wide variation in the
proportion of inadequate smears between general prac-
tices, with 23% of general practices showing evidence of
special cause variation – 12% showing low special cause
variation and 11% showing high special cause variation.
However, the majority of practices (77%) are consistent
with common cause variation.
Analysis of inadequate smears by cytology laboratory
We also explored the inter-laboratory variation in the pro-
portion of inadequate smears. The results are plotted on a
P-chart (Figure 2). Laboratories 1 and 2 show evidence of
special cause variation with exceptionally high propor-
tions of inadequate smears. Laboratories 3 and 4 show
special cause variation with very low proportions of inad-
equate smears.
Analysis of inadequate smears by general practice and 
cytology laboratory
To provide further insight into the interaction between the
two sources of variation (general practice and cytology
laboratory), we analysed the proportion of inadequate for
each general practice by cytology laboratories. We pro-
duced six P-charts one for each laboratory (Figure 3). TheBMC Public Health 2004, 4:25 http://www.biomedcentral.com/1471-2458/4/25
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mean proportion of inadequate smears ranged from
12.7% (laboratory 1) to 6.7% (laboratory 6).
Two of the six practices served by laboratory 1 show spe-
cial cause variation. Six of the 40 practices served by labo-
ratory 2 show special cause variation. One of the seven
practices served by laboratory 3 shows special cause varia-
tion. Four of the 41 practices served by laboratory 4 show
special cause variation. Practices served by laboratory 5
and by laboratory 6 show common cause variation.
Further analysis of inadequate smear rates
It not clear whether a high or low inadequate rate is pref-
erable; either too many smears are being rejected unneces-
sarily or inadequate smears are being analysed
inappropriately. To investigate this further data were
obtained on the results of laboratories nationally[1].
No relationship was found between the proportion of
smears reported as inadequate and the positive predictive
value of a smear in all 156 English laboratories [P = NS].
The positive predictive value of a smear is the percentage
of referrals following a smear that have grade 2 cervical
intraepithelial neoplasia or worse[1]. The step-down mul-
tivariate regression found only the proportion of smears
classified as negative to predict the proportion classified
as inadequate (beta coefficient = -0.319; P < 0.001). How-
ever, this explained little of the variation in the rates
reported as inadequate (R squared = 0.082), suggesting
that laboratories classifying larger proportions of smears
as inadequate do not report higher proportions of moder-
ate or severe dyskaryosis.
Discussion
Our study shows that there is wide variation in the pro-
portion of inadequate smears amongst our 100 general
practices, with 23% showing evidence of special cause var-
iation which merit further investigation to identify possi-
ble causes. However the vast majority of general practices
(77%) are consistent with common cause variation,
Control chart of the proportion of inadequate smears across the 100 general practices in the health authority Figure 1
Control chart of the proportion of inadequate smears across the 100 general practices in the health authority.
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which, according to Shewhart's theory of variation, is best
addressed by introducing fundamental changes to the
underlying process.
The National Institute for Clinical Excellence (NICE) has
recently recommended the adoption of liquid based cytol-
ogy (LBC), in part because it is associated with signifi-
cantly lower proportions of inadequate smears from 9%
to 1.6% [11]. This constitutes a fundamental change in
the cytology process. However, the inadequate smear rates
reported were based on only three pilot site laboratories,
the evaluation of which states that the long term reduc-
tion of the rate of inadequate smears cannot be assessed
from the data reported[12]. The systematic review that
informed the NICE decision also cites studies that show
an overall mean inadequate rate of 1.4% (5% and 95%
percentile 0.3% and 9.1%) for conventional cytology and
0.8% (5% and 95% percentile 0.1% and 5.5%) for
LBC[13]. These studies also show great heterogeneity with
either method and were not consistent with the current
mean inadequate rate of 9% in NHS practice. This is
reflected in NICE's statement that although LBC offers a
decrease in the proportion of inadequate specimens "the
literature reveals a wide and overlapping range in this pro-
portion with both conventional smears and liquid-based
methods."[11]
Although LBC technology is potentially associated with
significant reductions in the proportion of inadequate
smears, we cannot be confident that the impact of change
will be readily discernable in general practices/laborato-
ries because (a) it is not clear that the results of the pilot
evaluations are generalisable to practices/laboratories
with special cause variation, and (b) there is potential
interaction between the new technology and the existing
but as yet unidentified special cause variation. As a first
step we would recommend that special causes at these
general practices/laboratories be identified (and where
Control chart of the proportion of inadequate smears across laboratories (1–6) in the health authority Figure 2
Control chart of the proportion of inadequate smears across laboratories (1–6) in the health authority.
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appropriate eliminated) before introducing changes to
the underlying process. The following guidance has been
recommended [8] in investigating special cause variation
– check the data, check the case-mix, check the process,
check the resources and finally check the individuals
involved. The full benefits of LBC will only be realised if
its use in practice is optimised. Under the philosophy of
continual improvement, control charts, even in the pres-
ence of very low inadequate rates, offer a way of doing this
because a key feature of the control chart methodology is
that "special cause" variation is, by definition, economic
to find and remove[3].
Our approach differs from the current methods employed
in the NHS to analyse variations in inadequate smear
rates. At present, quality assurance targets are set from the
10th to the 90th percentiles of the distributions for labora-
tories nationally[1]. However, this fails to recognise that
results from different laboratories cannot be assumed to
be consistent with common cause variation, even in the
10th–90th percentile, as we have shown. In addition, a tar-
get based approach seems to focus attention on those lab-
oratories who have "missed the target", implying that
there is no "need" for "on target" laboratories to take
action. In sharp contrast Shewhart's approach requires
action for both special and common cause variation and
so is able to support efforts for continual improvement.
We have undertaken a comparative analysis between gen-
eral practices and laboratories. It would be very useful to
investigate how the proportion of inadequate smears
change over time (eg quarterly), for each laboratory and
for each general practice. This longitudinal analysis would
complement the cross-sectional analysis and provide a
more complete picture of the variation in the proportion
of inadequate smears.
Control chart of the proportion of inadequate smears across GP practices in the health authority sub-grouped by laboratory Figure 3
Control chart of the proportion of inadequate smears across GP practices in the health authority sub-grouped by laboratory. 
Each panel shows the control chart for a laboratory (1–6 in panel header). For each cytology laboratory, the mean proportion 
of inadequate smears is shown by a dotted horizontal line with accompanying upper and lower control limits.
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Conclusion
Control charts offer an action-oriented way of analysing
cervical smear data. By highlighting areas for further
investigation they act as a tool for hypothesis generation
about the causes of variation. In this way they direct us
towards the most efficient action that will achieve quality
improvement.
This study has shown that control charts can be used to
analyse routine cervical data at a health authority level.
Two distinct sources of variation in the inadequate smear
data can be identified; that associated with laboratories
and that associated with GP practices.
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